{"id":"https://openalex.org/W2092991344","doi":"https://doi.org/10.1046/j.1462-8902.2001.00037.x","title":"Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia","display_name":"Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia","alternate_titles":[],"publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2092991344","doi":"https://doi.org/10.1046/j.1462-8902.2001.00037.x","mag":"2092991344","pmid":"https://pubmed.ncbi.nlm.nih.gov/11843950"},"language":"en","primary_location":{"id":"doi:10.1046/j.1462-8902.2001.00037.x","doi":"https://doi.org/10.1046/j.1462-8902.2001.00037.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1462-8902.2001.00037.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2092991344"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113596148","display_name":"Gerald M. Reaven","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gerald M. Reaven","raw_affiliation_strings":["Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA. greaven@cumed.stanford.edu","Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA. greaven@cumed.stanford.edu","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"raw_affiliation_string":"Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113596148"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":6.5992,"has_fulltext":false,"cited_by_count":102,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97728335,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"4","issue":"s1","first_page":"13","last_page":"18"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8669999837875366},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9710000157356262},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.7559999823570251},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hyperinsulinemia","display_name":"hyperinsulinemia","score":0.9200000166893005},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9629999995231628},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.753000020980835},{"id":"https://openalex.org/keywords/procoagulant-state","display_name":"procoagulant state","score":0.7210000157356262},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9639999866485596},{"id":"https://openalex.org/keywords/endothelial-cell-adhesion-molecules","display_name":"endothelial adhesion molecules","score":0.7699999809265137},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.6809999942779541},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7289999723434448},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.5709999799728394},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8579999804496765}],"concepts":[{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.7613428831100464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7211444973945618},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.6808222532272339},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6513678431510925},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6459859609603882},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6173413991928101},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5701349973678589},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.5549945831298828},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.5264450311660767},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4716198742389679},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.46733200550079346},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.41347160935401917},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.39306169748306274}],"mesh":[{"descriptor_ui":"D000078790","descriptor_name":"Insulin Secretion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005342","descriptor_name":"Fibrinolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1462-8902.2001.00037.x","doi":"https://doi.org/10.1046/j.1462-8902.2001.00037.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1462-8902.2001.00037.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:11843950","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11843950","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W69884986","https://openalex.org/W1874374293","https://openalex.org/W1936800019","https://openalex.org/W1982368308","https://openalex.org/W2038508340","https://openalex.org/W2042894344","https://openalex.org/W2047070188","https://openalex.org/W2056340128","https://openalex.org/W2083695537","https://openalex.org/W2084148825","https://openalex.org/W2087914367","https://openalex.org/W2088631399","https://openalex.org/W2091066652","https://openalex.org/W2092917684","https://openalex.org/W2093894290","https://openalex.org/W2114102308","https://openalex.org/W2121176680","https://openalex.org/W2123946565","https://openalex.org/W2146765277","https://openalex.org/W2337454357","https://openalex.org/W3198570063"],"related_works":["https://openalex.org/W2410412606","https://openalex.org/W2168933286","https://openalex.org/W2422198244","https://openalex.org/W2417536824","https://openalex.org/W2061694846","https://openalex.org/W2119946403","https://openalex.org/W4234295004","https://openalex.org/W2113317508","https://openalex.org/W2101892683","https://openalex.org/W2138241187"],"abstract_inverted_index":{"Recent":[0],"evidence":[1],"from":[2],"the":[3,32,88,103,197,218],"United":[4],"Kingdom":[5],"Prospective":[6],"Diabetes":[7],"Study":[8],"convincingly":[9],"demonstrates":[10],"that":[11,51,85,195],"good":[12],"glycaemic":[13],"control":[14],"is":[15,27,105],"difficult":[16],"to":[17,30,47,62,87,100,151,180,206],"achieve":[18],"and,":[19],"despite":[20],"its":[21],"positive":[22],"impact":[23],"on":[24,171],"microvascular":[25],"complications,":[26],"not":[28],"sufficient":[29],"reduce":[31,207],"risk":[33,209],"of":[34,42,72,90,126,146,168,177,217],"coronary":[35],"heart":[36],"disease":[37],"(CHD).":[38],"Syndrome":[39,184],"X--a":[40],"cluster":[41],"abnormalities":[43,194],"associated":[44,119,191],"with":[45,67,120,142,192,214],"resistance":[46],"insulin-mediated":[48],"glucose":[49],"uptake":[50],"have":[52],"been":[53],"implicated":[54],"in":[55,65,107,123,162],"accelerating":[56],"atherogenesis--provides":[57],"a":[58,81,152],"useful":[59],"clinical":[60],"concept":[61],"prevent":[63],"CHD":[64],"patients":[66],"type":[68,187],"2":[69,188],"diabetes.":[70],"Components":[71],"syndrome":[73],"X":[74,185],"can":[75],"include":[76],"hypertension,":[77],"hyperinsulinaemia,":[78,143,226],"dyslipidaemia,":[79,140],"and":[80,110,117,174,186,227],"procoagulant":[82],"state,":[83],"changes":[84],"contribute":[86],"development":[89],"atherosclerosis.":[91],"Low-density":[92],"lipoprotein":[93,129,132],"cholesterol":[94,133],"(LDL-C)":[95],"levels":[96,114,134],"are":[97,115,118,135,190],"usually":[98],"close":[99],"normal,":[101],"but":[102],"LDL-C":[104],"present":[106],"abnormally":[108],"small":[109],"dense":[111],"particles.":[112,130],"Triglyceride":[113],"elevated":[116],"an":[121],"increase":[122],"postprandial":[124],"accumulation":[125],"atherogenic,":[127],"remnant":[128],"High-density":[131],"typically":[136],"low.":[137],"This":[138],"particular":[139],"along":[141,213],"induces":[144],"expression":[145,167],"plasminogen":[147],"activator":[148],"inhibitor-1,":[149],"contributing":[150],"prothrombotic":[153],"state.":[154],"In":[155],"addition,":[156],"plaque":[157],"formation":[158],"may":[159],"be":[160],"accelerated":[161],"insulin-resistant":[163],"subjects":[164],"by":[165],"increased":[166,175],"adhesion":[169,179],"molecules":[170],"endothelial":[172,182],"cells":[173],"rate":[176],"monocyte":[178],"cultured":[181],"cells.":[183],"diabetes":[189],"multiple":[193],"enhance":[196],"atherosclerotic":[198],"process.":[199],"The":[200],"opportunities":[201],"for":[202,222],"new":[203],"therapeutic":[204],"approaches":[205],"cardiovascular":[208],"will":[210],"undoubtedly":[211],"evolve":[212],"our":[215],"understanding":[216],"complex":[219],"factors":[220],"responsible":[221],"insulin":[223],"resistance,":[224],"compensatory":[225],"CHD.":[228]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2092991344","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
